346603-63-2

Basic information

• Product Name: Methyl 2-Methyl-3-(trifluoroMethyl)benzoate
• Synonyms: Methyl 2-Methyl-3-(trifluoroMethyl)benzoate;2-Methyl-3-(trifluoromethyl)benzoic acid methyl ester
• CAS NO: 346603-63-2
• Molecular Formula: C₁₀H₉F₃O₂
• Molecular Weight: 218.1724696
• Mol File: 346603-63-2.mol

Chemical Properties

• Boiling Point: 220℃
• Flash Point: 68℃
• Appearance: /
• Density: 1.231
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Methyl 2-Methyl-3-(trifluoroMethyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-Methyl-3-(trifluoroMethyl)benzoate(346603-63-2)
• EPA Substance Registry System: Methyl 2-Methyl-3-(trifluoroMethyl)benzoate(346603-63-2)

Safety Data

• Hazardous Substances Data: 346603-63-2(Hazardous Substances Data)

Usage

Uses

Used in Chemical Research:
Methyl 2-methyl-3-(trifluoromethyl)benzoate is used as a research compound for its unique property of having a trifluoromethyl group attached to a benzoate ester. This characteristic makes it valuable in various chemical research applications, where its properties can be explored and utilized for the development of new compounds and materials.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, methyl 2-methyl-3-(trifluoromethyl)benzoate can be used as an intermediate or building block in the synthesis of various pharmaceutical compounds. Its unique structure and properties may contribute to the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
Methyl 2-methyl-3-(trifluoromethyl)benzoate may also find applications in the agrochemical industry, where it can be used as a precursor or intermediate in the synthesis of various agrochemicals, such as pesticides and herbicides. Its unique properties may contribute to the development of more effective and environmentally friendly agrochemicals.
Used in Flavor and Fragrance Industry:
Due to its potential sweet or fruity smell, methyl 2-methyl-3-(trifluoromethyl)benzoate can be used as a flavoring agent or fragrance ingredient in the food and cosmetics industries. Its unique aroma profile may add a distinct character to various products, enhancing their sensory appeal.

Upstream product

• 62089-35-4 2-methyl-3-(trifluoromethyl)benzoic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 
• 680-15-9 2,2-difluoro-2-(fluorosulfonyl)acetate 
• 52570-33-9 methyl 3-iodo-2-methylbenzoate 

Downstream Products

• 1256290-47-7 [2-methyl-3-(trifluoromethyl)phenyl]methanol-d2 
• 1407232-94-3 (S)-4-methylsulfanyl-2-(1-oxo-4-trifluoromethyl-1,3-dihydro-isoindol-2-yl)-butyric acid methyl ester 
• 346603-68-7 methyl 2-(bromomethyl)-3-(trifluoromethyl)benzoate 

Relevant articles and documents

Pyridazone derivative and its uses

The present invention belongs to the pharmaceutical field, specifically relates to a pyridazone derivative and its uses, compounds thereof and pharmaceutically acceptable salts, solvates including hydrates, polycrystallines, prodrugs, co-crystallines, tau

Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity

A series of analogs of the immunomodulary drugs lenalidomide (1) and pomalidomide (2), in which the amino group is replaced with various isosteres, was prepared and assayed for immunomodulatory activity and activity against cancer cell lines. The 4-methyl and 4-chloro analogs 4 and 15, respectively, displayed potent inhibition of tumor necrosis factor-α (TNF-α) in LPS-stimulated hPBMC, potent stimulation of IL-2 in a human T cell co-stimulation assay, and anti-proliferative activity against the Namalwa lymphoma cell line. Both of these analogs displayed oral bioavailability in rat.

ISOINDOLINONE DERIVATIVES

The present invention relates to compounds of the formula I, as well as pharmaceutically-acceptable salts thereof, pharmaceutical compositions containing said compounds and methods of using said compounds in the treatment or prophylaxis of diseases and disorders. The compounds and compositions disclosed herein are glucokinase activators useful for the treatment or prophylaxis of metabolic diseases and disorders, for example diabetes mellitus, including type II diabetes mellitus.

THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS

This invention relates to the use of thiazolopyrimidinone derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3' OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3Kδ, PI3Kβ, and/or PI3Kγ

Tricyclic compounds

The present invention is to provide novel tricyclic compounds having leukotriene antagonistic action and represented by the formula: wherein R1 represents a halogen atom, etc., R2 represents a nitro group, etc., A represents a 5-membered or a 6-membered heteroaromatic ring group containing 1 to 3 hetero atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, etc., B represents a formula: —OCH2—, etc., X represents a sulfur atom, etc., Y represents C1-C10 alkylene group which may have a halogen atom, etc. as a substituent(s), Z represents a carboxyl group whic may be protected, etc., represents a single bond or a double bond, m is an integer of 1 to 4, n is an integer of 1 to 3, or a pharmaceutically acceptable salt thereof.